News

Latest draft work programme of cluster 5: climate, energy and mobility now available

Published on | 4 years ago

Programmes Energy Transport Climate/Environment

The launch of the full Horizon Europe programme is now very close.

Here you can find the latest version of the work programme for cluster 5 climate, energy and mobility.

This is still a draft version so minor changes to the texts are still possible.

If you want information regarding the background of these calls you can contact the PC representatives lut.bollen@vlaanderen.be (energy/climate) and hilde.vermeulen@vlaanderen.be (mobility)

You can also email the NCP’s bart.decaesemaeker@vlaio.be and pascal.verheye@vlaio.be  if you would like to receive more information on the NCP services regarding Horizon Europe.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1786 articles available search in articles 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.